50268-154-13 : NDC 2026 Code

50268-154-13 : Capecitabine ( Capecitabine )

Additionally :

You can get information about “50268-154-13” NDC code in 50268-154-13 in HTML format

HTML | 50268-154-13 in TXT (Plain Text) format

TXT | 50268-154-13 in PDF (Portable Document Format)

PDF | 50268-154-13 in XML format

XML formats.

NDC Code : 50268-154-13 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50268-154-13",
    "PackageDescription": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-154-13)  &gt; 1 TABLET in 1 BLISTER PACK (50268-154-11) ",
    "NDC11Code": "50268-0154-13",
    "ProductNDC": "50268-154",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Capecitabine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Capecitabine",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20180312",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA204741",
    "LabelerName": "AvPAK",
    "SubstanceName": "CAPECITABINE",
    "StrengthNumber": "500",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2022-09-14",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20231231",
    "StartMarketingDatePackage": "20180312",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}